- Home
- HROW vs NG Comparison
HROW vs NG Comparison
Compare HROW & NG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HROW | NG |
|---|---|---|
| Founded | 1998 | 1984 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.5B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | HROW | NG |
|---|---|---|
| Price | $46.30 | $9.88 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 3 |
| Target Price | ★ $68.86 | $10.17 |
| AVG Volume (30 Days) | 529.1K | ★ 2.6M |
| Earning Date | 11-10-2025 | 01-22-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $250,042,000.00 | N/A |
| Revenue This Year | $39.05 | N/A |
| Revenue Next Year | $40.48 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 47.83 | N/A |
| 52 Week Low | $20.85 | $2.26 |
| 52 Week High | $51.30 | $10.90 |
Technical Indicators
Market Signals| Indicator | HROW | NG |
|---|---|---|
| Relative Strength Index (RSI) | 57.54 | 59.50 |
| Support Level | $44.19 | $9.56 |
| Resistance Level | $47.44 | $10.01 |
| Average True Range (ATR) | 2.68 | 0.42 |
| MACD | -0.24 | -0.03 |
| Stochastic Oscillator | 56.39 | 65.68 |
Price Performance
Historical ComparisonAbout HROW Harrow Inc.
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.
About NG Novagold Resources Inc.
Novagold Resources Inc operates in the gold mining industry, focused on advancing the Donlin Gold project in Alaska. The Donlin Gold project is held by Donlin Gold LLC (Donlin Gold), a limited liability company owned equally by wholly owned subsidiaries of NOVAGOLD and Barrick Gold Corporation (Barrick). The company includes exploration and development activities of gold and other presious metals.